BTIG raised the firm’s price target on DocGo (DCGO) to $8 from $7 and keeps a Buy rating on the shares. The company is showing increased demand for the care-gap closure business, its core transport business is performing well, and BTIG is positive on the focus on maintaining margin, with SG&A reduction, and core growth, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DCGO:
- DocGo acquires PTI Health, terms undisclosed
- 3 Best Stocks to Buy Now, 1/17/2025, According to Top Analysts
- DocGo Extends Share Repurchase Program to 2025
- DocGo approves extension of expiration date of share repurchase program
- DocGo and SHL Telemedicine partner to put 12-lead devices in health care units